Literature DB >> 11393288

Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA.

Jürgen H Helbig, Søren A Uldum1, P Christian Lück, Timothy G Harrison1.   

Abstract

The new BinaxNOW Immunochromatographic (ICT) Assay for the detection of Legionella pneumophila antigens was used to test 535 urine specimens from patients with and without Legionnaires' disease. The specificity, calculated by testing 112 samples from patients with pneumonia of aetiologies other than Legionella infection, and 167 urine specimens from urinary tract infections, was found to be 97.1% if the manufacturer's guidelines were followed. However, it was determined that the 'false positive' results characterised by very weak bands could be discounted by re-examination of the results at 60 min, yielding a specificity of 100%. With this minor modification of the procedure applied to examination of urine samples from 117 patients with legionellosis confirmed by isolation of L. pneumophila and 70 patients who had seroconverted to L. pneumophila serogroup 1, sensitivity was calculated to be 79.7%. In comparison, the sensitivities of the Binax Urinary Antigen Enzyme Immunoassay (EIA) and Biotest Urin Antigen EIA were estimated to be 79.1 and 83.4%, respectively. Eleven cases (5.9%) were positive by BinaxNOW assay but negative by Binax or Biotest EIA, or both. The sensitivities of all assays increased to c. 94% if only diagnosis of cases confirmed by isolation of serogroup 1 L. pneumophila was considered, although the sensitivity for infections caused by L. pneumophila serogroup 1 monoclonal antibody (MAb) subgroup Bellingham was significantly lower than for other MAb subgroups. The Biotest EIA recognised 10 (45%) of the 22 cases not caused by L. pneumophila serogroup 1, whereas the two Binax kits detected only three each. The ICT assay BinaxNOW can be recommended as a rapid specific test for the diagnosis of Legionnaires' diseases caused by L. pneumophila serogroup 1, although very weak bands should be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393288     DOI: 10.1099/0022-1317-50-6-509

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  42 in total

1.  Comparison of polymerase chain reaction and two urinary antigen detection kits for detecting Legionella in clinical samples.

Authors:  M Koide; F Higa; M Tateyama; H Sakugawa; A Saito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-04       Impact factor: 3.267

2.  Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  Carmen Guerrero; Carmen M Toldos; Genoveva Yagüe; Cristobal Ramírez; Tomás Rodríguez; Manuel Segovia
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

3.  Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands.

Authors:  Ed P F Yzerman; Jeroen W den Boer; Kamilla D Lettinga; Joop Schellekens; Jacob Dankert; Marcel Peeters
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

4.  Real-time PCR assay targets the 23S-5S spacer for direct detection and differentiation of Legionella spp. and Legionella pneumophila.

Authors:  Bjorn L Herpers; Bartelt M de Jongh; Kim van der Zwaluw; Erik J van Hannen
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  Centrifugal ultrafiltration method for rapid concentration of Legionella pneumophila urinary antigen.

Authors:  S Blanco; C Prat; M A Pallarés; L Matas; J Domínguez
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

6.  Value of serological testing for diagnosis of legionellosis in outbreak patients.

Authors:  Almudena Rojas; M Dolores Navarro; Francisca E Fornés; Estefanía Serra; Encarnación Simarro; José Rojas; Joaquín Ruiz
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

8.  Evaluation of Rapid U Legionella Plus Test, a new immunochromatographic assay for detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  B M W Diederen; M F Peeters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

9.  Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila.

Authors:  P Elverdal; C S Jørgensen; S A Uldum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-09       Impact factor: 3.267

10.  Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease.

Authors:  Jürgen H Helbig; Søren A Uldum; Sverker Bernander; Paul Christian Lück; Günther Wewalka; Bill Abraham; Valeria Gaia; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.